Iroject Injection 500 mg/10 ml contains ferric carboxymaltose, an intravenous iron preparation used for the treatment of iron deficiency anemia. It is indicated when oral iron therapy is ineffective, not tolerated, or when rapid replenishment of iron stores is required. This formulation helps restore hemoglobin levels efficiently and improves overall oxygen transport in the body.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Ferric Carboxymaltose 500 mg/10 ml

Mechanism of Action

Ferric carboxymaltose is a stable iron complex that releases bioavailable iron into the bloodstream in a controlled manner after intravenous administration. The released iron is utilized in the bone marrow for hemoglobin synthesis and red blood cell production, while also replenishing iron stores in the liver and reticuloendothelial system.

Indications

Iroject Injection is indicated for:

• Iron deficiency anemia in adults
• Patients intolerant or unresponsive to oral iron therapy
• Postpartum iron deficiency anemia
• Anemia associated with chronic kidney disease
• Pre-operative or post-operative iron deficiency requiring rapid correction
• Conditions requiring fast restoration of iron levels

Dosage and Administration

• Administered via intravenous injection or infusion only
• Dosage is determined based on hemoglobin level, body weight, and iron deficit
• May be given as a single dose or repeated doses depending on clinical requirement
• Must be administered in a healthcare facility under medical supervision
• Patients should be monitored for hypersensitivity reactions during and after administration

Possible Side Effects

Common side effects include:

• Headache
• Nausea
• Dizziness
• Injection site reactions (pain, swelling, discoloration)
• Flushing

Less common but serious side effects:

• Hypersensitivity or allergic reactions
• Hypotension
• Hypophosphatemia (low phosphate levels)
• Fever or chills

Precautions

• Should only be administered in settings equipped to manage allergic reactions
• Regular monitoring of hemoglobin, ferritin, and iron levels is recommended
• Use cautiously in patients with liver disease
• Avoid use in patients with iron overload conditions
• Not recommended during early pregnancy unless clearly necessary

Contraindications

• Known hypersensitivity to ferric carboxymaltose or any component
• Iron overload disorders (e.g., hemochromatosis, hemosiderosis)
• Anemia not caused by iron deficiency

Drug Interactions

• Do not use simultaneously with oral iron preparations
• May affect MRI results due to iron content
• Use cautiously with other parenteral iron products

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store below 30°C
• Do not freeze
• Protect from light
• Keep out of reach of children

Important Notes

Iroject Injection 500 mg/10 ml provides rapid and effective correction of iron deficiency anemia when oral therapy is insufficient. It should always be administered under strict medical supervision to ensure safe and effective treatment outcomes.